Compare key investment metrics of 237690 and 한미약품 in real time. Both stocks belong to the RNA 치료제 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- For dividend-focused investors, 한미약품 has the edge — dividend yield 0.47% vs 237690's 0.4%.
- On earnings-based valuation, 한미약품 trades at a lower PER — 31.43x vs 237690's 36.94x. A lower PER can suggest undervaluation, but differences in growth expectations should also be considered.
- By market capitalization, 한미약품 is larger — ₩5.4T vs 237690's ₩2.6T. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 237690's current price of 124,500원 sits at about 47% of its 52-week range (81,900원–172,100원).
- 한미약품's current price of 423,000원 sits at about 41% of its 52-week range (266,500원–648,000원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 237690 | 한미약품 |
|---|---|---|
| Price | 124,500원 | 423,000원 |
| PER | 36.94배 | 31.43배 |
| PBR | 4.24배 | 4.13배 |
| Dividend Yield | 0.4% | 0.47% |
| Market Cap | ₩2.6T | ₩5.4T |
| 52-Week High | 172,100원 | 648,000원 |
| 52-Week Low | 81,900원 | 266,500원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 237690 or 한미약품?
As of 2026-07-06, 한미약품 has the lower PER — about 31.43x vs 237690's 36.94x. PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share; a lower PER may suggest undervaluation, but growth expectations should also be considered.
What is the dividend yield difference between 237690 and 한미약품?
As of 2026-07-06, 한미약품 offers the higher dividend yield — about 0.47% vs 237690's 0.4%. Dividend yield measures annual dividends as a percentage of the stock price and fluctuates with dividend policy and price movements.
How to compare 237690 and 한미약품?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.